Ozempic 0.5mg

Ozempic® 0.5 mg is a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes, following the initial 0.25 mg starter dose.

🌟 Product Overview

• Name: Ozempic® (semaglutide)
• Strength: 0.5 mg solution for injection
• Form: Pre-filled pen for subcutaneous use
• Class: GLP-1 (Glucagon-Like Peptide-1) receptor agonist

💉 Key Features

• Therapeutic Dose: After 4 weeks on the 0.25 mg starter dose, patients typically increase to 0.5 mg once weekly for ongoing treatment.
• Mechanism of Action: Stimulates insulin release when blood sugar is high, reduces glucagon secretion, and slows gastric emptying to help regulate glucose levels.
• Administration: Injected under the skin (abdomen, thigh, or upper arm) once weekly, at any time of day, with or without meals.
• Convenience: Supplied in a pre-filled pen that delivers either 0.25 mg or 0.5 mg doses, designed for ease of use.

⚕️ Indications

• Primary Use: Treatment of adults with type 2 diabetes mellitus, in combination with diet and exercise, to lower blood sugar levels.
• Additional Benefit: May support weight reduction, though it is not primarily indicated as a weight-loss drug.

⚠️ Important Safety Information

• Boxed Warning: In animal studies, semaglutide has been associated with thyroid C-cell tumors. Ozempic should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Common Side Effects: Nausea, vomiting, diarrhea, abdominal pain, and constipation.
• Precautions: Not recommended for patients with type 1 diabetes or diabetic ketoacidosis. Use with caution in patients with pancreatitis history.

📦 Packaging

• Supplied as a pre-filled pen delivering doses of 0.25 mg or 0.5 mg.
• Each pen contains multiple doses and should be stored refrigerated until first use.